<DOC>
	<DOC>NCT01272180</DOC>
	<brief_summary>This study will evaluate the safety and immunogenicity of combination vaccines as compared to the reference vaccines</brief_summary>
	<brief_title>Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adolescents aged 10 through 25 years of age inclusive at the time of enrollment. History of any meningococcal vaccine administration; Current or previous, confirmed or suspected disease caused by N. meningitidis; Pregnant or nursing (breastfeeding) mothers; Females of childbearing age who have not used or do not plan to use acceptable birth control measures, for the duration of the study; Any serious, chronic, or progressive disease; Known or suspected impairment/alteration of the immune system; Receipt of blood, blood products and/or plasma derivatives, or a parenteral immunoglobulin preparation within the previous 90 days; History of severe allergic reactions after previous vaccinations or hypersensitivity to any vaccine component.</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Meningococcal</keyword>
	<keyword>Seroresponse</keyword>
</DOC>